Relationship between Platelet Serotonin Uptake Sites and Measures of Impulsivity, Aggression, and Craving among African-American Cocaine Abusers

American Journal on Addictions

Volumn 12, Issue 5, 2003, Pages 432-447

  Patkar, Ashwin A ^a,c   Gottheil, Edward ^a   Berrettini, Wade H ^b   Hill, Kevin P ^a   Thornton, Charles C ^a   Weinstein, Stephen P ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; PAROXETINE; SEROTONIN RECEPTOR;

ADULT; AGGRESSIVENESS; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG BINDING SITE; DRUG DETERMINATION; DRUG RECEPTOR BINDING; FEMALE; HUMAN; IMPULSIVENESS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NEGRO; OUTPATIENT; RECEPTOR DOWN REGULATION; THROMBOCYTE MEMBRANE; UNPLEASANT SENSATION; WITHDRAWAL SYNDROME;

EID: 0345495689     PISSN: 10550496     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2003.tb00486.x     Document Type: Article

References (81)

1. McElroy SL, Pope HG Jr, Hudson JI, et al. Kleptomania: a report of 20 cases. Am J Psychiatry. 1991;148:652-657.
2. Salomon RM, Mazure CM, Delgado PL, et al. Serotonin function in aggression: the effect of acute plasma tryptophan depletion in aggressive patients. Biol Psychiatry. 1994;35:570-572.
3. Linnoila M, Virkkunen M, Scheinin M, et al. Low cerebrospinal fluid 5-hydroxyindolacetic acid concentration differentiates impulsive from non-impulsive violent behavior. Life Sci. 1983;33:2609-2614.
4. Ramirez LF, McCormick RA, Russo AM, et al. Patterns of substance abuse in pathological gamblers undergoing treatment. Addict Behav. 1983;8:425-428.
5. McCormick RA, Smith M. Aggression and hostility in substance abusers: the relationships to abuse patterns, coping style, and relapse triggers. Addict Behav. 1995;20:555-562.
6. Allen TJ, Moeller G, Rhoades HM, et al. Subjects with a history of drug dependence are more aggressive than subjects with no drug use history. Drug Alcohol Depend. 1997;46:95-103.
7. DeMoja CA. Scores on locus of control and aggression for drug addicts, users, and controls. Psychol Rep. 1997;80:40-42.
8. Moeller FG, Steinberg JL, Petty F, et al. Serotonin and impulsive/aggressive behavior in cocaine-dependent subjects. Prog Neuropsychopharmacol Biol Psychiatry. 1994;18:1027-1035.
9. Yudofsky SC, Silver JM, Hales RE. Cocaine and aggressive behavior: neurobiological and clinical perspectives. Bull Menninger Clin. 1993;57:218-226.
10. Conrod PJ, Pihl RO, Stewart SH, et al. Validation of a system of classifying female substance abusers on the basis of personality and motivational risk factors for substance abuse. Psychol Addict Behav. 2000;14:243-256.
11. Martin CS, Earleywine M, Blackson TC, et al. Aggressivity, inattention, hyperactivity, and impulsivity in boys at high and low risk for substance abuse. J Abnorm Child Psychol. 1994;22:177-203.
12. Brady KT, Myrick H, McElroy S. The relationship between substance use disorders, impulse control disorders, and pathological aggression. Am J Addict. 1998;7:221-230.
13. Dervaux A, Bayle FJ, Laqueille X, et al. Is substance abuse in schizophrenia related to impulsivity, sensation seeking, or anhedonia? Am J Psych. 2001;158:492-494.
14. Bushnell JA, Wells JE, Oakley-Brown MA. Impulsivity in disordered eating, affective disorder, and substance use disorder. Br J Psychiatry 1996;169:329-333.
15. Linnoila VM, Virkunnen M. Aggression, suicidality, and serotonin. J Clin Psychiatry. 1992;53:46-51.
16. Virkunnen M, Kallio E, Rawlings R, et al. Personality profiles and state aggressiveness in Finnish alcoholic, violent offenders, fire setters, and healthy volunteers. Arch Gen Psychiatry. 1994;51:28-33.
17. Stanley B, Molcho A, Stanley M, et al. Association of aggressive behavior with altered serotonergic function in patients who are not suicidal. Am J Psychol. 2000;157:609-614.
18. Coccaro EF, Kavoussi RJ, Sheline YL, et al. Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet. Arch Gen Psychiatry. 1996;53:531-536.
19. Steiger H, Leonard S, Kin NY, et al. Childhood abuse and tritiated-paroxetine binding in bulimia nervosa: implications of borderline personality disorder. J Clin Psychiatry. 2000;61:428-435.
20. 3H-imipramine binding sites on platelets of conduct disordered children. Neuropsychopharmacology. 1987;1:55-62.
21. 3H]paroxetine binding related to impulsive suicide attempts and borderline personality disorder. Biol Psychiatry. 1998;43:740-746.
22. Hollander E, Stein DJ, DeCaria CM, et al. Serotonergic sensitivity in borderline personality disorder: preliminary findings. Am J Psychiatry. 1994;151:277-280.
23. Coccaro EF, Kavoussi RJ, Sheline YI, et al. Impulsive aggression in personality disorder correlates with platelet 5-HT2A receptor binding. Neuropsychopharmacology. 1997;16:211-216.
24. Olafsson K, Jorgensen S, Jensen HV. Fluvoxamine in the treatment of demented elderly patients: a double-blind, placebo controlled study. Acta Psychiatr Scand. 1992;85:453-456.
25. Hellings JA, Kelley LA, Gabrielli WF, et al. Sertraline response in adults with mental retardation and autistic disorder. J Clin Psychiatry 1996;57:333-336.
26. 11C]methyl-L-tryptophan trapping in impulsive subjects with borderline personality disorder. Am J Psychiatry 2001;158:775-782.
27. Chiavegetto S, Dawson VL, Mamounas LA, et al. Brain serotonin dysfunction accounts for aggression in male mice lacking neuronal nitric oxide synthase. Proc Natl Acad Sci USA. 2001;98:1277-1281.
28. Lesch KP, Merschdorf U. Impulsivity, aggression, and serotonin: a molecular psychobiological perspective. Behav Sci Law. 2000;18:581-604.
29. Buydens-Branchey L, Branchey M, Fergeson P, et al. The meta-chlorophenylpiperazine challenge test in cocaine addicts: hormonal and psychological responses. Biol Psychiatry. 1997;41:1071-1086.
30. Moss HB, Yao JK, Panzak GL. Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse. Biol Psychiatry. 1990;28:325-338.
31. Handelsman L, Kahn RS, Sturiano C, et al. Hostility is associated with a heightened prolactin response to meta-chlorophenylpiperazine in abstinent cocaine addicts. Psychiatry Res. 1998;80:1-12.
32. Fishbein DH, Lozovosky D, Jaffe JH. Impulsivity, aggression, and neuroendocrine responses to serotonergic stimulation in substance abusers. Biol Psychiatry. 1989;25:1049-1066.
33. 3H]-binding in type I and type II alcoholism. Human Psychopharmacology. 1995;10:1-6.
34. 3H-imipramine binding in heroin and cocaine addicts. Mol Neurobiol. 1995;11:21-29.
35. 3H]paroxetine binding in healthy control subjects and alcohol-dependent patients and their relationships to impulsivity. Psych Res. 2000;96:51-61.
36. Dauost M, Lhuintre JP, Ernouf D, et al. Ethanol intake and 3H-serotonin uptake, II: a study in alcoholic patients using platelets 3H-paroxetine binding. Life Sci. 1991;48:1977-1983.
37. Childress AR, McLellan AT, Natale M, et al. Mood states can elicit conditioned withdrawal and craving in opiate abuse patients. NIDA Res Monogr. 1987;76:137-144.
38. Anton RF, Moak DH, Latham PK. The obsessive compulsive drinking scale: a new method of assessing outcome in alcoholism treatment studies. Arch Gen Psychiatry. 1996;53:225-231.
39. Modell JG, Glasser FB, Cyr L, et al. Obsessive compulsive characteristics of craving for alcohol abuse and dependence. Alcohol Clin Exp Res. 1992;16:272-274.
40. Loh EA, Roberts DCS. Break points on a progressive ratio schedule of reinforcement by cocaine increase following depletion of forebrain serotonin. Psychopharmacology. 1990;101:262-267.
41. Kosten TA, Kosten TR, Gavin FH, et al. An open trial of sertraline for cocaine abuse. Am J Addict. 1991;1:349-353.
42. Budyn-Branchey L, Branchey M, Fergeson P, et al. Craving for cocaine in addicted users: role of serotonergic mechanisms. Am J Addict. 1997;6:65-73.
43. Satel SL, Kosten TR, Schuckit MA, et al. Should protracted withdrawal from drugs be included in DSM-IV? Am J Psychiatry. 1993;150:695-704.
44. Little KY, McLaughlin DP, Zhang L, et al. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry. 1998;155:207-213.
45. Belej T, Manji D, Sioutis S, et al. Changes in serotonin and norepinephrine uptake sites after chronic cocaine pre- vs post-withdrawal effects. Brain Res. 1996;736:287-296.
46. van Erp AM, Miczek KA. Aggressive behavior, increased accumbal dopamine, and decreased cortical serotonin in rats. J Neurosci. 2000;20:9320-9325.
47. Ramammorthy S, Bauman AL, Moore KR, et al. Antidepressant and cocaine sensitive human transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci. 1993;90:2542-2546.
48. Lesch K-P, Wolozin BL, Murphy DL, et al. Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J Neurochem. 1993;60:2319-2322.
49. Prasad PD, Leibach FH, Mahesh VB, et al. Human placenta as a target organ for cocaine action: interaction of cocaine with the placental serotonin. Placenta. 1994;15:267-278.
50. Marcusson J, Ross SB. Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets. Psychopharmacology. 1990;102:145-155.
51. 3H-paroxetine binding to rat cortical membranes. Eur J Pharmacol. 1985;118:107-114.
52. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV disorders (SCID-IV). Washington DC: American Psychiatric Press; 1997.
53. Buss AH, Durkee A. An inventory for assessing different kinds of hostility. J Consult Psychol. 1957;21:343-348.
54. Barrat ES. Factor analysis of some psychometric measures of impulsiveness and anxiety. Psychol Rep. 1985;16:547-554.
55. Zuckerman M. Impulsive sensation seeking and its behavioral, psychophysiological, and biochemical correlates. Neuropsychobiology. 1993;28:30-36.
56. McCormack HM, Horne DJ, Sheather S. Clinical applications of visual analog scales: a critical review. Psychol Med. 1988;18:1007-1019.
57. Beck AT, Steer RA. Beck Depression Inventory. San Antonio, Tex: The Psychological Corporation, Harcourt, Brace and Jovanovich, 1987.
58. McLellan AT, Luborsky L, Cacciola J, et al. The fifth edition of the Addiction Severity Index: cautions, additions and normative data. J Nerv Men Dis. 1992;168:26-33.
59. Satel SL, Delgado PL, Charney DS. Serotonin mediation of cue induced craving. Society Neuroscience Annual Meeting. 1991;348:888.
60. 2+ response, and 5-HT content in winter seasonal affective disorder. Biol Psychiatry. 1994;36:458-466.
61. Lowry O, Rosebrough NJ, Farr AL, et al. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265-275.
62. Bligh-Glover W, Kolli TN, Shapiro-Kulnane L, et al. The serotonin transporter in the midbrain of suicide victims with major depression. Biol Psychiatry. 2000;47:1015-1024.
63. Moeller FG, Dougherty DM, Rustin T, et al. Antisocial personality disorder and aggression in recently abstinent cocaine-dependent subjects. Drug Alcohol Depend. 1997;44:175-182.
64. Marazatti D, Conti L. Aggression, hyperactivity, and platelet imipramine binding. Acta Psychiatr Scand. 1991;84:209-211.
65. Brown CS, Kent TA, Bryant SG, et al. Blood platelet uptake of serotonin in episodic aggression. Psychiatry Res. 1989;27:5-12.
66. Moeller FG, Steinberg JL, Petty F, et al. Serotonin and impulsive/aggressive behavior in cocaine-dependent subjects. Prog Neuropsychopharmacol Biol Psychiatry. 1994;18:1027-1035.
67. Zuckerman M. Impulsive sensation seeking and its behavioral, psychophysiological, and biochemical correlates. Neuropsychobiology. 1993;28:30-36.
68. Netter P, Hennig J, Roed IS. Serotonin and dopamine as mediators of sensation seeking behavior. Neuropsychobiology. 1996;34:155-165.
69. Childress A, Ehrman R, McLellan AT, et al. Conditioned craving and arousal in cocaine addiction: a preliminary report. NIDA Res Monogr. 1988;81:74-80.
70. Dackis CA, Gold MS. New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Biobehav Rev. 1985;9:469-477.
71. 3H-paroxetine binding to platelets from healthy volunteers. Biol Psychiatry. 1993;34:356-360.
72. Blier P, de Montigny C, Chaput Y. Modifications of the serotonin system by antidepressant treatments: implication for the therapeutic response in major depression. J Clin Psychopharmacol. 1987;7(suppl):24S-35S.
73. Yan Q, Reith ME, Yan S. Enhanced accumbal dopamine release following 5HT (2A)-receptor stimulation in rats pretreated with intermittent cocaine. Brain Res. 2000;863:254-258.
74. Murphy DL, Mellow AM, Sunderland T, et al., eds. Serotonin in Major Pychiatric Disorders. Washington DC: American Psychiatric Press; 1990.
75. Gross-Isserhoff R, Israeli M, Biegon A. Autoradiographic analysis of tritiated imipramine binding in the human brain post mortem: effects of suicide. Arch Gen Psychiatry. 1989;46:237-241.
76. Corash L, Costa JL, Shafer B, et al. Heterogeneity of human whole blood platelet subpopulations, III: density-dependent differences in subcellular constituents. Blood. 1984;64:185-193.
77. Miller NS, Summers GL, Gold MS. Cocaine dependence: alcohol and other drug dependence and withdrawal characteristics. J Addict Dis. 1993;12:25-35.
78. Ballenger JC, Goodwin FK, Major LF, Brown GL. Alcohol and central serotonin metabolism in man. Arch Gen Psychiatry. 1979;36:224-227.
79. Ribeiro E, Bettiker RL, Bogdanov M, Wurtman RJ. Effects of systemic nicotine on serotonin release in rat brain. Brain Res. 1993;621:311-318.
80. Harrison AA, Liem YT, Markou A. Fluoxetine combined with a serotonin 1 A receptor antagonist revered reward deficits observed during nicotine and amphetamine withdrawal in rats. Neuropharmacology. 2001;25:55-71.
81. Greenberg BD, Tolliver TJ, Huang S-J, et al. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet. 1999;88:83-87.